Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by canadafanon Feb 22, 2024 2:44pm
185 Views
Post# 35893992

Fun to watch

Fun to watch

It is amazing to see tge likes of Armedescape & others spewing their FUD. 

It needs to be clearly understood Armedescape et. al. Destroyed what was once a reasonable chat site.
That being over on yahoo, as a private group...yes a few years ago.
once the in- place moderator left that site, Aramed posted day after day after day, random rantings.
Claiming to be a shareholder? Turning the site into a useless washroom wall type of name calling.

I guess it is logical to invest in something & then dedicate massive time to bashing thst investment & those who support it?
Moving on. 

A couple of interesting points brought up lately.
One being DR. Matt Cofee " royalties". .
As the last remaining founder if Onc, he does hold the patents of the corperationn & as part of founding agreements, the founders were to be paid a perpetual royalties from any income directly related to the sale, lease or  s partnership Pelareorep.
At onset was a small amount, being single digit %. 
The departing founders were paid out some exit setelment & forfitted their fixture royalty rights.
The royalty payout comes with a built- in annual reduction. Meaning less % to be paid as each year passes.
Could even be b3 zero now, i don't know. Definitely not what it oncee was.
motivation? Conflict of interest ? 

simple math & logic even Armed can understand, there is HUGE motivation for Matt to get Pela approved, or a business deal ASAP.
The longer it waits, his royalty % drops each year.
FWIW , he was paid about $30k royalties out of The $5 million upfront deal done with A.N. Back in 2017.
The number showed up in financials.
Riding that into our friend Uber , who goes to great lengths proclaiming Onc is a scam,.
The opportunity for perpetual royalties from on- going sales of Pela for cancer treatments, plus his shares & options, far exceeds his annual wages.
Keep in mind , Matt held just over a million shares presplit. Yes now 100k shares or so.
his share value has depreciated just as everyone else's
Yes her earns an annual salary.
So did the CEO of boing! He lied to congress, allowed the second flight to kill a second plane load of people.
Yes he was let go. An amazing severance in the tens of millions.
My point, CEOs make good $.
What has ONC accomplished ?
Well yes, 25 years of misdirected trials. Yet within last few years massive accomplishments.
alongside Roche , they have quickly ( in Onc & biotech time), moved forward and obtained fast track approval from FDA for Pela to be moved into phase 3 for both Pancreatic cancer & MBC.
As well as after a competitive process approval from Pan Can to be part of the precicion promise program they had in place.
regrettably, for everyone! 

PanCan closed down the precicion promise program.
now, 
Mr. Uber. You claim over & over oncolytics biotech is a fraud?
I encourage you to advance your surperior Intelect & findings...& please inform all of the principal players involved with Onc. Please ASAP get on the phone & let them know.
list included, FYI.
Roche, Incyte, Pfizer, PamCan, AIO Germany, The FDA, university of Calgary, both IRS & Canadian revenue Canada, The dozen of trial  location Drs & administrators that have been overseeing the trials, the accountants & lawyers of each of the mentioned pharma companies.
The patients who have been part of trials.
The legally bound analysts ( 6 or so) , who who have been following Onc for years.
Please Uber .....call then NOW & let's shut the fraud down!
Or perhaps they should be advised & shut you down for liable & slander.
it is easy to throw mud, stones, FUD, however you have zero evidence to substantiate your " fraud" claim.
i expect you can read? 

All of the trials announced. Yes some failed , some were great, some so- so...were all prefaced by co- therapy agreements.
Using the existing Roche Gobblet as an example. Prior to the start was precluded by extensive due diligence on the side of Roche. 

tecentrique is one of their lead cancer drugs. They would NOT EVEN THINK of associating thier corporate name & especially the good name if tecentriq with a fraud.
Uber howver claims superior knowledge, supported by his circus, so please let Roche know ASAP
afterall, they just announced an advancement of the 3rd out of 4 trial cohorts.
Now, that I have cleared that up ( tried previous but the yahoo moderator always edited me out)...
What about , the near term? Onc must have a business deal inplace to proceed with phase 3.
They have said phase 3 plans will be inplace first half of this year.
delayed ...PanCan previously discussed...
so, IMHO for mutiple reasons they need a deal ASAP
Q4/ yr end is usually Early March, with an announcement due typically NOW.
who knows , maybe Uber can step up inform everyone of his superior information & shut the whole thing down?lol

 

 

 

 

<< Previous
Bullboard Posts
Next >>